Published in Mol Med Rep on January 08, 2015
New Insights for Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev (2015) 0.94
Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease. Neural Regen Res (2015) 0.94
Erythropoietin and diabetes mellitus. World J Diabetes (2015) 0.80
The Relationship between the Bcl-2/Bax Proteins and the Mitochondria-Mediated Apoptosis Pathway in the Differentiation of Adipose-Derived Stromal Cells into Neurons. PLoS One (2016) 0.79
Regeneration in the nervous system with erythropoietin. Front Biosci (Landmark Ed) (2016) 0.76
Charting a course for erythropoietin in traumatic brain injury. J Transl Sci (2016) 0.76
Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy. Curr Neurovasc Res (2016) 0.75
Complement and sepsis-induced heart dysfunction. Mol Immunol (2016) 0.75
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med (2004) 24.47
Mitochondria and apoptosis. Science (1998) 23.41
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med (1998) 11.58
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet (2007) 6.88
Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res (1980) 6.39
Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J Cell Biol (2001) 3.09
Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem (1999) 3.07
Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation (2003) 2.68
Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30
Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev (2006) 2.06
Myocardial cell injury in septic shock. Crit Care Med (1999) 1.82
The non-haematopoietic biological effects of erythropoietin. Br J Haematol (2008) 1.81
Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev (1998) 1.72
Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med (2009) 1.68
Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J Biol Chem (2006) 1.65
Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem (2000) 1.65
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. CMAJ (2007) 1.38
Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biophys Res Commun (2003) 1.31
Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol Sci (2004) 1.30
Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis (2007) 1.23
Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacol Rep (2008) 1.13
Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leuk Res (2005) 1.12
Advances in understanding sepsis. Eur J Anaesthesiol Suppl (2008) 1.07
Sepsis: from bench to bedside. Clinics (Sao Paulo) (2008) 0.91
Dexamethasone inhibits stimulation of pulmonary endothelins by proinflammatory cytokines: possible involvement of a nuclear factor kappa B dependent mechanism. Intensive Care Med (2001) 0.86
Cardiac troponin-I as a marker of myocardial dysfunction in children with septic shock. Swiss Med Wkly (2004) 0.85
Recent insights into the pathogenesis of severe sepsis. Crit Care Resusc (2005) 0.84